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Abstract 
Background: To evaluate effect of caffeine and 
vitamin D3 on body weight of BALB/c mice. 
Methods:  In this experimental study thirty BALB/c 
mice, three weeks old with average weight 12-14 g 
were taken and divided into three  groups with 10 
mice (5 male, 5 female) in each group. The control 
group G1 was given normal diet prepared at National 
Institute of Health Islamabad with liberal water 
intake.  Each animal in experimental group G2 was 
given 10mg of caffeine per100g body weight on 
alternate day, three days in a week by oral gavage for 
60 days. All animals of G3 were given caffeine 
10mg/100g body weight on alternate day, three days 
a week and vitamin D3 0.1µg per day by oral gavage 
for 60 days.   The effect of caffeine and vitamin D3 
was assessed  by measuring the body weight of the 
mice at the end of the experiment. 
Results: Mean final body weight of mice of control 
group G1 was 31.2 ± 1.932 g while the mean final 
body weight of experimental groups G2 and G3 was 
found to be 27.1 ± 2.025 g and 29.2 ± 2.098 g .   Mean 
final body weight of mice of experimental group G2 
was less as compared to control group G1 and 
experimental group G3. 
Conclusion:  The body weight of the mice was 
reduced due to caffeine consumption while vitamin 
D3 administration ameliorated the deleterious effect 
of caffeine on the body weight.  
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Introduction 
Caffeine is one of the most researched food 
components, with the vast majority of dietary 
contributions coming from beverage consumption. 
Caffeine intake varies across different types of 
beverages and in different population groups.  
Caffeine is one of many constituents in foods that can 
exert physiological effects.  Global consumption of 
caffeine has been estimated at 120,000 tons per year, 
making it world’s most popular psychoactive 
substance.1 
Caffeine consumption has been associated with weight 
loss and its ingestion provokes an increase in the 
metabolic rate.2  Metabolic stimulation appears to be 
dose dependent and in rats it has been found to be 
partly due to endogenous catecholamine release and 
partly to the intrinsic calorigenic effect of caffeine.3 
There was an increase in both plasma free fatty acids 
(FFA) and urinary catecholamine excretion in man 
after caffeine ingestion. The FFA response was the 
result of catecholamine induced lipolysis.4  Caffeine 
was regarded as a thermogenic agent that in 
combination with slimming regimens could be of use 
in promoting the loss of body energy.5 Caffeine can be 
deemed as a noncaloric thermogenic agent that is 
usually consumed in many beverages. While a mild 
fever, anorexia, insomnia, and a loss of weight have 
been reported in women who frequently consumed the 
equivalent of 1.5 to 1.8 g caffeine per day as coffee , it 
is well tolerated by human subjects. 6  There had not 
been any fatalities as a result of caffeine consumption, 
however, a toxic dose was believed to be about 10 g or 
more.2 
Caffeine increases basal metabolic rate in adults.7   
Lipid oxidation has also been shown to increase in 
subjects performing exercise after caffeine ingestion.8 
The resting metabolic rate of lean and post-obese 
human volunteers was raised by 3-4% as a result of 
single-dose oral administration of 100 mg caffeine.9  
The studies in animals evaluated that methylxanthines 
including caffeine were responsible for reduction of 
body weight as well as body fat by both anorectic and 
thermogenic effects.10 
Vitamin D is a fat soluble vitamin and its chemical 
structure was determined in the 1930s.  In the early 
20th century, the therapeutic use of cod liver oil, 
containing vitamin D, led to a dramatic decrease in the 
incidence of rickets.11  Vitamin D can be obtained from 
diet, supplements or from endogenous production in 
the skin.  The cutaneous production is very effective 
and even a few minutes in the sun tends to increase 
circulating vitamin D concentration.12  Severe 
deficiency of vitamin D can cause rickets in children 
and osteomalacia in adults.  13 Vitamin D exists in two 
forms, namely ergocalciferol (vitamin D2) and 
cholecalciferol (vitamin D3).  Ergocalciferol (vitamin 
D2) is obtained from plants, in particular mushrooms, 
whereas all other dietary sources as well as the 
cutaneous production of vitamin D are cholecalciferol 
(vitamin D3).  Vitamin D, and in particular 
1,25(OH)2D, is of critical importance to bone.14 
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Material and Methods  
This laboratory based randomized control trial was 
conducted in the Department of Anatomy, Army 
Medical College Rawalpindi, in collaboration with 
National Institute of Health (NIH) Islamabad from 
October 2014 to October 2015.  Approval of ethical 
committee on animal experiments, of the Army 
Medical College, Rawalpindi was obtained for the 
study.  A total of thirty, 15 male and 15 female 
BALB/c mice of three weeks weighing 12-14 g were 
studied. Mice were kept in a well ventilated room and 
under a temperature range of 20-26°C.  They were 
randomly divided into three groups.  Each group 
contained 5 male and 5 female mice (10 BALB/c mice 
in each group).  Male and female mice were kept in 
separate cages to elude pregnancy.15  The mice of 
group G1 served as controls and were given standard 
laboratory diet for 60 days.  BALB/c mice in G2 group 
were given caffeine at a dose of 10mg/100gm bw, on 
alternate day, 3 days a week for 60 days by oral 
gavage (Fig. 1).  All animals of G3 were given caffeine 
10mg/100g body weight on alternate day, three days 
in a week and vitamin D3 0.1 µg per day by oral 
gavage for 60 days.  The body weights of all the 
animals were recorded at the beginning of the study 
and at the end of the experiment.  Data analysis was 
done using IBM-SPSS version 20 while ANOVA test 
was applied followed by Post Hoc Tukey`s Test for 
intergroup comparison of quantitative variable based 
on means and standard deviations (mean ± SD).  A p 
value < 0.05 was considered significant.  
 
 
 
Fig 1.  Photograph showing administration of drug 
through oral gavage 
 
Results 
The initial and final body weights (mean ± SD) of G1 
animals were found to be 13.1 ± 0.876 g and 31.2 ± 
1.932 g, respectively.  The initial and final body 
weights (mean ± SD) of G2 animals were 13.1 ± 0.876 g 
and 27.1 ± 2.025 g, respectively.  Similarly the initial 
and final body weights of G3 were 13.1 ± 0.876 g and 
29.2 ± 2.098 g, respectively (Table-1).     
Table 1: Initial and final body weight of animals 
in control group G1, experimental groups G2  
andG3 
 
Animal 
Weight (g) 
Group G1 
Mean±SD 
(n=10) 
Group G2 
Mean±SD 
(n=10) 
p-value 
Initial 13.1±0.876 13.1±0.876 1.0 
Final 31.2±1.932 27.10±2.025 0.000472* 
*p value ≤ 0.05 is statistically significant 
The comparison of initial body weights of animals 
among control group G1 and experimental groups G2 
and G3 was statistically insignificant (Table -2); 
however, the change in final body weight of 
experimental groups G2 and G3 was found to be 
statistically significant (p<0.05) in comparison with 
control group G1 (Table-2) .  The comparison of body 
weight of male and female animals within the groups 
G1, G2 and G3 was statistically insignificant (Table - 3).  
Table-2: Comparison of initial and final body 
weight of animals among groups G1, G2 and G3 
Animal 
Weight (g) 
Group G1 vs. 
Group G2 
Group G1 vs. 
Group G3 
Group G2  
vs.  
Group G3 
p-value p-value p-value 
Initial 1.000 1.000 1.000 
Final 0.000207* 0.039685* 0.035173* 
*P value ≤ 0.05 is statistically significant 
Table 3: Body weight of male and female 
animals within the groups G1, G2 and G3 
Animal 
Weight (g) 
Male vs.  
Female G1 
Male vs.  
Female G2 
Male vs.  
Female G3 
p-value p-value p-value 
Initial  0.7404 0.7404 0.6938 
Final  0.1028 0.0836 0.0649 
p- value ≤ 0.05 is statistically significant 
 
Discussion 
The consumption of caffeine is increasing day by day 
throughout the world.  The public and the scientific 
community have raised voices against its detrimental 
effects on human health. 16   A 2011 research 
determined that high caffeine intake was linked with 
an alteration in two genes that enhance the rate of 
caffeine breakdown. The individuals who had this 
transmutation on both chromosomes took 40 mg more 
caffeine per day as compared to others. In present 
study the initial body weight was found statistically 
insignificant among the groups G1, G2 and G3 , as well 
as during comparison between male and female 
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animals of groups G1, G2 and G3 .  However, the final 
body weights were statistically significant when 
experimental group G2 (caffeine fed) was compared 
with control group G1 . Although, the final body 
weight was found insignificant in comparison between 
male and female groups of  G1, G2 and G3 .The 
findings of this study are similar to one performed by 
Huang et al.(2002) on the effect of caffeine in male 
Wristar rats where the final body weight after 
exposure to caffeine was appreciably reduced than 
that of the control group. Theseresults indicated that 
caffeine caused a significant decrease in accretion of 
body weight.17  Caffeine causes stimulation of the 
resting metabolic rate by enhancing the catabolism of 
fatty acid, thus inducing a greater loss of body 
weight.2  It has been proposed that caffeine 
consumption which increased lipolysis was partially 
due to higher catecholamine discharge.4 
Caffeine promotes lipolysis by restraining the cyclic 
nucleotide phosphodiesterase that is used for 
catalyzing the transformation of cyclic AMP to AMP.  
The high level of tissue cyclic AMP concentrations 
mobilize inactive hormone-sensitive lipase and 
stimulate lipolysis.18 Caffeine acts in the presence of 
lipolytic hormones, such as adrenaline, and causes an 
increase in cyclic AMP concentrations which is greater 
than that caused by the hormones alone.  This shows 
that caffeine stimulates not only resting energy 
expenditure but lipid mobilization and fat oxidation 
also.4  In this study, improvement was noticed in the 
final animal weight of G3 group co-treated with 
caffeine and vitamin D3.  Sufficient dietary intake of 
vitamin D is necessary for building and maintaining 
healthy bones.19  Vitamin D supplementation results in 
decreased bone turnover and increased bone mineral 
density.20  A 5 to 7% increase in the mean degree of 
mineralization of bone tissue was observed due to 
vitamin D.21  Vitamin D enhanced the absorption of 
calcium from gut and influenced the overall 
mineralization of the skeleton.20  Vitamin D has been 
universally used for the prevention and treatment of 
osteoporosis and recognized as a bone resorbing 
hormone mostly in in-vitro studies.22 
 
Conclusion 
Caffeine caused negative effect on the accretion of 
body weight of the mice.  The deleterious effect of 
caffeine on body weight was ameliorated by the 
administration of vitamin D3.  Hence, vitamin D3 
antagonized partially the detrimental effect of caffeine 
on the accretion of body weight. 
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